History and background
Pharmacology is the science of receptors. This has been appreciated ever since pharmacology began to emerge as a separate discipline. Langley' and Ehrlich2 proposed the concept that a drug had to interact with a 'receptive substance' and that some form of binding of drug to receptor must occur. This idea was never seriously challenged but, equally, it remained an abstract concept without a physical counterpart. The presence of receptors in a particular tissue could be inferred from the action of drugs on endogenous substances, but nothing was known of the cellular or subcellular localization of the receptor, its structure, or its mechanism of action. In the last 15 years this, situation has been totally transformed. As this review will attempt to show, we now have a vast body of knowledge concerning the above questions for most of the 'classical' receptors, and also for many whose existence was not even suspected in the 1970s.
There is no single reason for these spectacular advances, which have parallels in many other branches of the life sciences. The following developments are, however, of major significance.
(i) The discovery of enkephalins and endorphins by Kosterlitz and Hughes.3 Apart from the obvious impact on opioid receptor research, this had wider repercussions. The idea of endogenous ligands for 'drug' receptors was hardly novel: acetylcholine was the earliest example, with the recognition that this endogenous agent recognized muscarinic and nicotinic receptors.4 Nevertheless, this discovery greatly encouraged collaboration between pharmacologists, physiologists and biochemists and emphasized areas of common interest.
(ii) The development of radiolabelled ligands for binding studies.5 '6 This has allowed the identification and quantitation of receptors and their sub-types in small quantities of tissue and, to some extent, permitted their anatomical and subcellular localization.
(iii) The delineation of signal transduction mechanisms for most, though not all, receptors. This has revealed quite unsuspected metabolic pathways linked to receptor activation, as well as the re-evaluation of known mechanisms.
(iv) As part of the above process, the increasing refinement of electrophysiological techniques for measuring electrical activity and ion flux across the cell membrane.7 (v) The extraordinarily rapid advances in the technology of molecular biology. This has already permitted the sequencing and cloning of several receptors.
In this review I will attempt to summarize some of the recent developments in this field. Much of this information is only just being incorporated into undergraduate teaching and may be rather unfamiliar. Needless to say, the primary literature is unmanageably vast. To give some idea of the scale, a review of dopamine receptors in 1980 included over 1200 references.8 I will frequently refer to more specialized reviews, especially those in the 'Trends' series of journals. (Table III) This brief review has concentrated on the basic aspects of recent receptor research. Even within those limits it has been very incomplete: for instance, nothing has been said of steroid receptors, which are not on the external cell membrane. 87 Nor have receptor synthesis, metabolism and internalization been discussed. 88 It is hoped that other articles will deal with these issues from a more clinical standpoint. Virtually no branch of medicine has remained unaffected, though all the implications have yet to be comprehended.
Radioligand binding
. group.bmj.com on January 27, 2018 -Published by http://pmj.bmj.com/ Downloaded from
